Dr. Stavros Melemenidis | Radiation | Excellence in Research

Dr. Stavros Melemenidis, Stanford University School of Medicine, United States

Dr. Stavros Melemenidis, DPhil, is a distinguished expert in radiation biology and medical physics, currently serving as the Director of the Pre-clinical Radiotherapy Core at Stanford University. With a D.Phil. in Radiation Biology from Oxford and a Medical Physics certification from UCLA, his research spans FLASH radiotherapy, molecular imaging, and dosimetry. At Stanford, he leads groundbreaking studies on high-dose radiation effects and radioprotective strategies. His work integrates advanced imaging, immunotherapy, and precision radiotherapy, contributing to cutting-edge cancer treatments. His expertise in 3D modeling, tumor imaging, and experimental radiotherapy techniques has earned him recognition in the field. 🎗️🔬

Professional Profile:

Scopus

Orcid

Suitability of Dr. Stavros Melemenidis for the Excellence in Research Award

Dr. Stavros Melemenidis is an outstanding candidate for the Excellence in Research Award, given his pioneering work in radiation biology, medical physics, and preclinical radiotherapy. As the Director of the Pre-clinical Radiotherapy Core at Stanford University, he leads cutting-edge studies in FLASH radiotherapy, molecular imaging, and precision dosimetry, significantly advancing cancer treatment. His multidisciplinary research integrates immunotherapy, tumor imaging, and high-dose radiation applications, setting new benchmarks in radiation oncology.

Education & Experience 🎓💼

📍 Cert. Medical Physics – UCLA (2022–2023)
🎓 D.Phil. Radiation Biology – University of Oxford (2010–2015) 🏛️
- Molecular imaging of lung metastases & angiogenesis
🎓 M.Sc. Radiation Biology – University of Oxford (2009–2010)
🎓 M.Sc. Radiometrics & Instrumentation – University of Liverpool (2008–2009)
🎓 B.Sc. Physics (Medical Applications) – University of Liverpool (2005–2008)
🎓 A.Eng. PC Systems & Equipment – Thessaloniki, Greece (1998–2000)

💼 Professional Experience:

🏥 Stanford University, Radiation Oncology (2020–Present)
- 🎯 Director, Pre-clinical Radiotherapy Core (2023–Present)
  - Oversees QA & dosimetry for preclinical irradiation
  - Develops organ-specific collimators & experimental components
- 🔬 Research Scientist, Radiation Therapy Division (2020–Present)
  - Specializes in FLASH radiotherapy experiments
  - Designs radiobiological studies & dosimetry protocols
- 🧬 Postdoctoral Fellow (2016–2020)
  - Developed in vivo tumor models integrating imaging, radiotherapy & immunotherapy
  - Focused on immune cell migration & radioprotective strategies
🏛️ University of Oxford, Radiation Oncology (2015)
- Postdoctoral Fellow – Developed PET/MRI imaging probes for metastasis detection

Professional Development 🚀

Dr. Melemenidis is at the forefront of radiation oncology innovations, merging clinical expertise with cutting-edge research. He has trained medical physicists, mentored graduate students, and led numerous radiotherapy technology advancements. 💡 His expertise in FLASH radiotherapy, precision dosimetry, and tumor imaging enhances cancer treatment protocols worldwide. 🌍🔬 He is an advocate for interdisciplinary collaboration, integrating machine learning, molecular imaging, and immunotherapy into his research. With 7+ years of experience in image-guided irradiation (PXi SmART), he continues to pioneer new methods for high-dose radiation applications, advancing medical science and patient outcomes. 🎗️⚡

Research Focus 🔬🧪

Dr. Melemenidis specializes in radiotherapy physics, molecular imaging, and immuno-radiotherapy. His work in FLASH radiotherapy explores how ultra-high dose rates can improve cancer treatment while minimizing damage to healthy tissues. 🏥💡 His molecular imaging research utilizes PET, MRI, and hyperpolarized gas imaging to detect tumor progression and response to therapy. 📡🧬 He is deeply involved in radioprotective strategies, studying how radiation affects immune cell migration and developing techniques to enhance radiotherapy precision. His research bridges preclinical and translational studies, contributing to next-generation radiotherapy treatments. 🚀🧑‍⚕️

Awards & Honors 🏆🎖️

🥇 Best Radiation Oncology Research Award – Stanford University (2023)
🏅 Innovation in FLASH Radiotherapy Award – AAPM (2022)
🎗️ Early Career Excellence Award – Radiation Research Society (2021)
🏛️ Oxford Medical Sciences Scholarship – University of Oxford (2010–2015)
🔬 Best Presentation in Preclinical Radiotherapy – ESTRO Conference (2020)